Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/26/21 EDT
592.15quote price arrow up+15.95 (+2.77%)
Volume
816,080
52 week range
441.00 - 686.62
Loading...
  • Open579.14
  • Day High594.22
  • Day Low575.61
  • Prev Close592.15
  • 52 Week High686.62
  • 52 Week High Date09/03/21
  • 52 Week Low441.00
  • 52 Week Low Date03/04/21

Key Stats

  • Market Cap63.336B
  • Shares Out106.96M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change22.57

KEY STATS

  • Open579.14
  • Day High594.22
  • Day Low575.61
  • Prev Close592.15
  • 52 Week High686.62
  • 52 Week High Date09/03/21
  • 52 Week Low441.00
  • 52 Week Low Date03/04/21
  • Market Cap63.336B
  • Shares Out106.96M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change22.57

RATIOS/PROFITABILITY

  • EPS (TTM)55.70
  • P/E (TTM)10.63
  • Fwd P/E (NTM)12.41
  • EBITDA (TTM)6.939B
  • ROE (TTM)51.32%
  • Revenue (TTM)12.384B
  • Gross Margin (TTM)86.85%
  • Net Margin (TTM)50.11%
  • Debt To Equity (MRQ)17.83%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:1801:18
Final Trades: MGM, REGN, IMAX & FCX

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab)...
P. Roy Vagelos M.D.
Chairman
Leonard Schleifer M.D., Ph.D.
President
George Yancopoulos M.D., Ph.D.
Co-President
Robert Landry
Chief Financial Officer
Daniel Van Plew
Executive Vice President
Address
777 Old Saw Mill River Rd
Tarrytown, NY
10591-6717
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
271.12+1.18+0.44%
BNTX
BioNTech SE
292.39-2.53-0.86%
ILMN
Illumina Inc
417.19-3.59-0.85%
MRNA
Moderna Inc
345.74-3.82-1.09%
GRFS
Grifols SA
13.52-0.14-1.02%